Active

INNOVENTIS PHARMA

Switched

BE0690813115

Rechtspersoon Public limited company 1 establishment

Vierschaar 6, 9250 Waasmunster Groothandel in parfumerieën en cosmetica

Active for

8 year, 6 months

Financials

Financial year 2025

Worth noting

  • Little cash and receivables against the short-term debts.

Gross margin

€ 689,522

▲ 15% vs 2024

Profit

Healthy

€ 1,561

▼ 62% vs 2024

Debts

Normal

€ 1.3 million

▲ 6% vs 2024

INNOVENTIS PHARMA from Waasmunster, company number BE0690813115, closed financial year 2025 with a result of € 1,561 after tax. For that financial year INNOVENTIS PHARMA recorded a gross margin of € 689,522 and equity of € 396,169. Compared with financial year 2024, the result moved from € 4,105 to € 1,561. The company is profitable. The buffer is growing. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on July 26, 2026.

What happened at INNOVENTIS PHARMA?

What happened at INNOVENTIS PHARMA in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

  • New annual accounts for financial year 2025: profit of € 1,561 (▼ 62% vs 2024). Source: NBB ↗
  • New establishment in Waasmunster. KBO
  • Start of the company according to the CBE. KBO

In short

From € 901 loss in 2021 to € 1,561 profit in 2025.

Best year ever: 2024, with € 4,105 profit.

On average € 121,000 of value added per employee in 2025.

A new publication or filing at INNOVENTIS PHARMA? We notify you, reason included.

Follow INNOVENTIS PHARMA

Need more data?

History

Every financial year, as far back as the National Bank goes.

Buffer

How long does the company survive without income?

Credit limit

Indicative credit limit, computed from the real figures.

Alerts

New annual account: profit halved. New
Gazette: capital increase of 250k. New

News about who you follow, reason included.

Databakkes Pro · first month free

Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.

Establishments

Establishment units

Physical locations of this company

Registered office

Vierschaar 6

9250 Waasmunster

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number
0690.813.115
VAT number
BE 0690.813.115
Registered office
Vierschaar 6, 9250 Waasmunster
Names & denominations
INNOVENTIS PHARMA
Enterprise type
Rechtspersoon
Legal form
Public limited company
Legal situation
Normale toestand
Start date
21 February 2018
Peppol
Active · Active since 31 Dec 2025
Activities · NACE

Groothandel in parfumerieën en cosmetica

Frequently asked questions

What is the enterprise number of INNOVENTIS PHARMA?
The enterprise number of INNOVENTIS PHARMA is BE0690813115.
What is the address of INNOVENTIS PHARMA?
The registered office of INNOVENTIS PHARMA is located at Vierschaar 6, 9250 Waasmunster.
When was INNOVENTIS PHARMA founded?
INNOVENTIS PHARMA was founded on 21 February 2018.
What is the main activity of INNOVENTIS PHARMA?
The main activity of INNOVENTIS PHARMA is "Groothandel in parfumerieën en cosmetica" (NACE code 46450).
Does INNOVENTIS PHARMA have a website?
No website is currently known for INNOVENTIS PHARMA.
How much profit did INNOVENTIS PHARMA make in 2025?
INNOVENTIS PHARMA posted a profit after taxes of € 1,561 in financial year 2025.
What is the revenue of INNOVENTIS PHARMA?
As a small company, INNOVENTIS PHARMA is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 689,522.
How many employees does INNOVENTIS PHARMA have?
According to the 2025 annual accounts, INNOVENTIS PHARMA has 5.7 full-time equivalents (FTE).
Where can I find the annual accounts of INNOVENTIS PHARMA?
INNOVENTIS PHARMA files its annual accounts with the Central Balance Sheet Office of the National Bank of Belgium. The key figures for recent financial years are available for free on this page.